EP2872482
AÐFERÐ VIÐ AÐ MEÐHÖNDLA BRJÓSTAKRABBAMEIN MEÐ SÉRTÆKUM ANDRÓGENVIÐTAKASTILLI (SARM)
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.3.2013EP published:
8.7.2020EP application number:
13817231.7
EP translation filed:
9.9.2020Grant published:
15.10.2020EPO information:
European Patent Register
Max expiry date:
6.3.2033Expiry date:
6.3.2026Next due date:
31.3.2026
Title:
A METHOD OF TREATING BREAST CANCERS WITH SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM)
Timeline
Today
7.3.2013EP application
8.7.2020EP Publication
9.9.2020Translation submitted
15.10.2020Registration published
6.3.2026Expires
Owner
Name:
Oncternal Therapeutics, Inc.Address:
3525 Del Mar Heights Road Suite 821, San Diego, CA 92130-2122, US
Inventor
Name:
DALTON, James, T.Address:
Lakeland, TN 38002, US
Name:
STEINER, Mitchell, S.Address:
Germantown, TN 38139, US
Name:
NARAYANAN, RameshAddress:
Cordova, TN 38018, US
Name:
AHN, SunjooAddress:
Memphis, TN 38120, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201261671366 PDate:
13.7.2012Country:
US
Number:
201261726274 PDate:
14.11.2012Country:
US
Classification
Categories:
A61K 31/167, A61K 31/325, A61P 35/04, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 18.2.2021
Expires: 6.3.2022
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 18.2.2022
Expires: 6.3.2023
Payer: Patice ehf.
Number: 11
Paid: 20.2.2023
Expires: 6.3.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 28.2.2024
Expires: 6.3.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 11.2.2025
Expires: 6.3.2026
Payer: Árnason Faktor ehf.